Akanda Corp. (AKAN)
NASDAQ: AKAN · IEX Real-Time Price · USD
0.117
-0.048 (-29.29%)
At close: Mar 28, 2024, 4:00 PM
0.128
+0.011 (9.69%)
After-hours: Mar 28, 2024, 7:59 PM EDT
Akanda Market Cap
Akanda has a market cap or net worth of $1.46 million as of March 28, 2024. Its market cap has decreased by -54.43% in one year.
Market Cap
1.46M
Enterprise Value
5.93M
1-Year Change
-54.43%
Ranking
Category
Stock Price
$0.12
Market Cap Chart
Since the IPO on March 15, 2022, Akanda's market cap has decreased from $115.61M to $1.46M, a decrease of -98.74%. That is a compound annual growth rate of -88.33%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Mar 27, 2024 | 700.00K | - |
Mar 26, 2024 | 700.00K | - |
Mar 25, 2024 | 700.00K | -30.00% |
Mar 22, 2024 | 1.00M | 25.00% |
Mar 21, 2024 | 800.00K | - |
Mar 20, 2024 | 800.00K | 14.29% |
Mar 19, 2024 | 700.00K | - |
Mar 18, 2024 | 700.00K | - |
Mar 15, 2024 | 700.00K | 16.67% |
Mar 14, 2024 | 600.00K | -14.29% |
Mar 13, 2024 | 700.00K | - |
Mar 12, 2024 | 700.00K | - |
Mar 11, 2024 | 700.00K | - |
Mar 8, 2024 | 700.00K | - |
Mar 7, 2024 | 700.00K | - |
Mar 6, 2024 | 700.00K | -12.50% |
Mar 5, 2024 | 800.00K | -11.11% |
Mar 4, 2024 | 900.00K | - |
Mar 1, 2024 | 900.00K | -10.00% |
Feb 29, 2024 | 1.00M | -9.09% |
Feb 28, 2024 | 1.10M | - |
Feb 27, 2024 | 1.10M | -8.33% |
Feb 26, 2024 | 1.20M | - |
Feb 23, 2024 | 1.20M | - |
Feb 22, 2024 | 1.20M | - |
View and export this data all the way back to 2022.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
NeuBase Therapeutics | 1.90M |
NanoVibronix | 1.80M |
Virax Biolabs Group | 1.77M |
180 Life Sciences | 1.53M |
Dermata Therapeutics | 1.47M |
Bluejay Diagnostics | 1.46M |
Galmed Pharmaceuticals | 1.30M |
Tharimmune | 1.18M |